Trial intelligence / Profile preview

Metformin for Obesity in Sri Lankan Children

NCT02274948Phase 4Completed

Sponsor
University of Colombo
Start
Jul 2014
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of liquid metformin (Aspargo Labs) in obesity (2 arms), sponsored by University of Colombo. Primary endpoints: Change in BMI Standard Deviation Score at 1 year and Change in Percentage Fat Mass Standard Deviation Score at 1 year. Started Jul 2014; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

obesity

Beyond the preview

Go deeper on NCT02274948.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02274948.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call